High-resolution structures of the SARS-CoV-2 2'- O -methyltransferase reveal strategies for structure-based inhibitor design.
Rosas-Lemus, M., Minasov, G., Shuvalova, L., Inniss, N.L., Kiryukhina, O., Brunzelle, J., Satchell, K.J.F.(2020) Sci Signal 13
- PubMed: 32994211 
- DOI: https://doi.org/10.1126/scisignal.abe1202
- Primary Citation of Related Structures:  
6W4H, 6W75, 6WJT, 6WKQ, 6WQ3, 6WRZ, 6WVN - PubMed Abstract: 
There are currently no antiviral therapies specific for SARS-CoV-2, the virus responsible for the global pandemic disease COVID-19. To facilitate structure-based drug design, we conducted an x-ray crystallographic study of the SARS-CoV-2 nsp16-nsp10 2'- O -methyltransferase complex, which methylates Cap-0 viral mRNAs to improve viral protein translation and to avoid host immune detection ...